Bullish & Foolish
Full TNXP fundamentals All 466 on the Survival Watch

TNXPTonix Pharmaceuticals Holding Corp.

Is Tonix Pharmaceuticals Holding struggling financially?

Yes, by its own account. Tonix Pharmaceuticals Holding told the SEC on 10 Aug 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Aug 2026

30/100

Fragile

Sector
Biotech/Pharma
Market cap
$215.2M
Source filing
10-Q 10 Aug 2026
Balance sheet
30 Jun 2026

Cash runway

  • 17months

    If the burn speeds up

    Empty by Nov 2027

  • 24months

    If it eases off

    Empty by Jun 2028

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$176.2M

÷

Cash burned over the last 12 months

$103.2M

What Tonix Pharmaceuticals Holding told the SEC

…requirements into early second quarter of 2027, but will not extend to 12 months from the issuance of these financial statements. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company continues to face significant challenges and uncertainties and must obtain additional funding through public and private financing and collaborative arrangements with…

Tonix Pharmaceuticals Holding Corp., Form 10-Q, filed 10 Aug 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 128.9% share-count increase The company issued stock. Each share now owns 56.3% less of the business than a year ago, before any change in the price.

Other Biotech/Pharma companies that filed the doubt